Download PDF
Thromb Haemost 1975; 33(03): 406-416
DOI: 10.1055/s-0038-1647902
National Conference on Thrombosis and Hemostasis, Dallas, Texas, 20.—22. November 1974
Schattauer GmbH

The Current Status of Platelet Suppressive Drugs in the Treatment of Thrombosis[*]

J Hirsh   **
1   Departments of Pathology and Clinical Epidemiology and Biostatistics, McMaster University Medical Centre, Hamilton, Ontario, Canada
2   Department of Medicine, University of Colorado Medical Center, Denver, Colorado, U.S.A.
,
M Gent
1   Departments of Pathology and Clinical Epidemiology and Biostatistics, McMaster University Medical Centre, Hamilton, Ontario, Canada
2   Department of Medicine, University of Colorado Medical Center, Denver, Colorado, U.S.A.
,
E Genton
1   Departments of Pathology and Clinical Epidemiology and Biostatistics, McMaster University Medical Centre, Hamilton, Ontario, Canada
2   Department of Medicine, University of Colorado Medical Center, Denver, Colorado, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 22 January 1975

Accepted 22 January 1975

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

 

* Presented at the National Conference on Thrombosis and Hemostasis, under the auspices of the Council on Thrombosis of the American Heart Association, Dallas, Texas, November, 1974.


** Please address all correspondence to Dr. J. Hirsh, Department of Pathology, McMaster University Medical Center, Hamilton, Ontario, Canada.


 

  • References

  • 1 Acheson J, Danta G, Hutchinson E. C. Controlled trial of dipyridamole in cerebral vascular disease. British Medical Journal 1969; 1: 614
    CrossrefPubMedGoogle Scholar
  • 2 Acheson J, Hutchinson E. C. Controlled trial of Clofibrate in cerebral vascular disease. Atherosclerosis 1972; 15: 177
    CrossrefPubMedGoogle Scholar
  • 3 Blakely J. A, Gent M, Sheth N, Vavrik M, Tannerya R. G. B, Smythe H. A. Platelets, drugs and longevity in a geriatric population. In: Hirsh J, Cade J. F, Gallus A. S, Schonbaum E. (eds.) Platelets Drugs and Thrombosis Karger, Basel; Switzerland: 284 1974
    Google Scholar
  • 4 Boston Collaborative Study Surveillance Group. Regular aspirin intake and acute myocardial infarction. British Medical Journal 1972; 1: 440
    PubMedGoogle Scholar
  • 5 Browse N. L, Hall J. H. Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis. Lancet 1969; 2: 718
    PubMedGoogle Scholar
  • 6 Carter A. E, Eban R, Perrett R. D. Prevention of post-operative deep venous thrombosis and pulmonary embolism. British Medical Journal 1971; 1: 312
    CrossrefPubMedGoogle Scholar
  • 7 Carter A. E, Eban R. Prevention of post-operative deep venous thrombosis in legs by orally administered hydroxychloroquine sulphate. British Medical Journal 1974; 3: 94
    CrossrefPubMedGoogle Scholar
  • 8 Clagett G. P, Schneider P, Rosoff C. B, Salzman E. W. The influence of aspirin on postoperative platelet kinetics and venous thrombosis. (In preparation.) 1974
    PubMedGoogle Scholar
  • 9 Dyken M. L, Kolar O. J, Jones F. H. Differences in the occurrence of carotid transient ischemic attacks associated with antiplatelet aggregation therapy. Stroke 1973; 4: 732
    CrossrefPubMedGoogle Scholar
  • 10 Elwood P. C, Cochrane A. L, Burr M. L, Sweetname P. M, Williams G, Welsby E, Hughes S. J, Renton R. A randomized controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. British Medical Journal 1974; 1: 436
    CrossrefPubMedGoogle Scholar
  • 11 Evans G. Effect of drugs that suppress platelet surface interaction on incidence of amaurosis fugax and transient cerebral ischemia. Surgical Forum 1972; 23: 239
    PubMedGoogle Scholar
  • 12 Evans G, Gent M. The effect of platelet suppressive drugs on arterial and venous thromboembolism. In: Hirsh J, Cade J. F, Gallus A. S, Schonbaum E. (eds) Platelets. Drugs and Thrombosis Karger, Basel; Switzerland: 1974: 258
    Google Scholar
  • 13 Feinstein A. R. Clinical Biostatistics: XVIII. The Clofibrate trials: Another dispute about contratrophic therapy. Clinical Pharmacology and Therapeutics 1972; 13: 953
    PubMedGoogle Scholar
  • 14 Freed M. D, Rosenthal A, Fyler D. Attempts to reduce arterial thrombosis after cardiac catheterization in children: Use of percutaneous technique and aspirin. American Heart Journal 283 87 No. 3 1974;
    CrossrefPubMedGoogle Scholar
  • 15 Friedewald W. T, Halperin M. Clofibrate in ischemic heart disease. Annals of Internal Medicine 1972; 76: 821
    CrossrefPubMedGoogle Scholar
  • 16 Gent A. E, Brook C. G. D, Foley T. H, Miller T. N. Dipyridamole: A controlled trial of its effect in acute myocardial infarction. British Medical Journal 1968; 4: 366
    CrossrefPubMedGoogle Scholar
  • 17 Group of Physicians of the Newcastle Upon Tyne Region. Trial of Clofibrate in the treatment of ischemic heart disease. British Medical Journal 1971; 4: 767
    CrossrefPubMedGoogle Scholar
  • 18 Harker L. A, Slichter J. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. New England Journal of Medicine 1970; 283: 1302
    CrossrefPubMedGoogle Scholar
  • 19 Harris W. H, Salzman E. W, Athanasoulis C, Waltman A. C, Baum S, De-Sanctis R. W. Comparison of warfarin, low molecular weight dextran, aspirin and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. (In preparation.) 1974
    PubMedGoogle Scholar
  • 20 Harrison M. J. G, Marshall J, Meadows J. C, Russell R. W. R. Effect of aspirin in amaurosis fugax. Lancet 1971; 2: 743
    PubMedGoogle Scholar
  • 21 Heady J. A. A cooperative trial on the primary prevention of ischaemic heart disease using Clofibrate: Design, methods and progress. British World Health Organization 1973; 48: 243
    PubMedGoogle Scholar
  • 22 Heikinheimo R, Jarvinen K. Acetylsalicylic acid and arteriosclerotic thromboembolic diseases in the aged. Journal of the American Geriatrics Society 1971; 19: 403
    CrossrefPubMedGoogle Scholar
  • 23 Hirsh J. Unpublished observations 1974
    PubMed
  • 24 Hynes K. M, Gau G. T, Rutherford B. D, Kazmier F. J, Frye R. L. Effect of aspirin on brachial artery occlusion following brachial arteriotomy for coronary arteriography. Circulation 1973; 47: 554
    CrossrefPubMedGoogle Scholar
  • 25 Kaegi A, Pineo G. F, Shimizu A, Trivedi H, Hirsh J, Gent M. Arteriovenous-shunt thrombosis: Prevention by sulfinpyrazone. New England Journal of Medicine 1974; 290: 304
    CrossrefPubMedGoogle Scholar
  • 26 Krasno L. R, Kidera G. J. Clofibrate in coronary heart disease. Effect on morbidity and mortality. Journal of the American Medical Association 1972; 219: 845
    PubMedGoogle Scholar
  • 27 Lindsay R. M, Prentice C. R. M, Ferguson D, Burton J. A, McNicol G. P. Reduction of thrombus formation on dialyser membranes by aspirin and RA 233. Lancet 1972; 2: 1287
    PubMedGoogle Scholar
  • 28 Medical Research Council (Report of the Steering Committee) Effect of aspirin on postoperative venous thrombosis. Lancet 1972; 2: 441
    PubMedGoogle Scholar
  • 29 Mundall J, von Kaulla K. N, Austin J. H. Effect of aspirin in amaurosis fugax. Lancet 1972; 1: 92
    PubMedGoogle Scholar
  • 30 O’Brien J. R. A trial of aspirin in the prevention of post-operative venous thrombosis. Thrombosis et Diathesis Haemorrhagica Suppl. 54: Thrombosis; Mechanisms and Control 1973; 345
    PubMedGoogle Scholar
  • 31 Paterson J. C. The pathology of venous thrombi. In: Sherry S, Brinkhous K. M, Genton E, Stengle J. M. (eds) Thrombosis. . Proceedings of National Academy of Sciences; Washington D. C: 1969: 321
    Google Scholar
  • 32 Preston F. E, Emmanuel I. G, Winfield D. A, Malia R. G. Essential thrombocythemia and peripheral gangrene. British Medical Journal 1974; 3: 548
    CrossrefPubMedGoogle Scholar
  • 33 Salzman E. W, Harris W. H, De-Sanctis R. W. Reduction in venous thromboembolism by agents affecting platelet function. New England Journal of Medicine 1971; 284 No. 23 1287
    CrossrefPubMedGoogle Scholar
  • 34 Scottish Society of Physicians (Research Committee) Ischaemic heart disease: A secondary prevention trial using Clofibrate. British Medical Journal 1971; 4: 775
    CrossrefPubMedGoogle Scholar
  • 35 Sevitt S. Venous thrombosis in injured patients (with some observations on pathogenesis). In : Sherry S, Brinkhous K. M, Genton E, Stengle J. M. (eds) Thrombosis. Proceedings of National Academy of Sciences; Washington, D. C.: 1969: 29
    Google Scholar
  • 36 Steele P, Genton E. Personal communication 1974
    PubMed
  • 37 Sullivan J. M, Harken D. E, Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. New England Journal of Medicine 1971; 284: 1391
    CrossrefPubMedGoogle Scholar
  • 38 Vreeken J, van Aken W. G. Spontaneous aggregation of blood platelets as a cause of idiopathic thrombosis and recurrent painful toes and fingers. Lancet 1971; 2: 1394
    PubMedGoogle Scholar
  • 39 Weily H. S, Steele P. P, Davies H, Pappas G, Genton E. Platelet survival in patients with substitute heart valves. New England Journal of Medicine 1974; 290: 534
    CrossrefPubMedGoogle Scholar
  • 40 Zekert F, Kohn F, Vormittag E. Prophylaxis of thromboembolic disease in traumatological patients. Proceedings of IV Congress of International Society on Hemostasis and Thrombosis Vienna 1973: 246
    PubMedGoogle Scholar